Statistics for BioVie (id:5386 BIVI)

Valuation metrics

Market cap

59.49M

Enterprise value

5.98M

Trailing P/E (ttm)

Forward P/E

-0.76

PEG ratio

-0.76

Price/Sales (ttm)

Price/Book (mrq)

1.34

Enterprise Value/Revenue

Enterprise Value/EBITDA

-0.19

Overview

Shares outstanding

17.76M

Float

4.72M

Shares short

187.74K

% Held by insiders

0.14%

% Held by institutions

0.10%

Average volume (10 days)

2.96M

Average volume (90 days)

Price summary

52-Week low

1.04

52-Week high

56.54

52-Week change

-1,534.43%

Beta

0.90

50-Day moving average

2.19

200-Day moving average

4.89

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

November 22th, 2019

Ex-dividend date

Last split factor

2:1

Last split date

August 06th, 2024

Financials

Fiscal year

Fiscal year ends

June 30th, 2024

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-66.69%

Return on equity

-208.26%

Income statement

Revenue (ttm)

Revenue per share (ttm)

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-31,950,208.00

Net income to common (ttm)

-33,006,956.00

Diluted EPS (ttm)

-7.30

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

23.84M

Total cash per share (mrq)

3.01

Total debt (mrq)

6.11M

Total Debt/Equity (mrq)

39.41

Current ratio (mrq)

257.10%

Book value per share (mrq)

2.50

Cash flow

Cash flow statement

-27,945,024.00

Levered free cash flow (LFCF)

-18,778,568.00